Courses

Course and Master Course Listings

In-depth, clinically-focused content to equip you with practical skills to help you meet the challenges of daily practice. Held in a small-group setting, attendance is limited.

• Courses

  Courses are designed to emphasize learning experiences that actively involve participants and include the opportunity for informal exchange with the faculty. Offered in four-hour (half-day), six-hour (full-day) and eight-hour (full-day) sessions, courses either review basic concepts in a special subject area or present advanced material on a circumscribed topic. Participants must purchase tickets to attend.

  Saturday, May 18, 2019

  Advanced Pharmacological Management for Depression: Applying the Latest Evidence-Based Treatment in Clinical Practice

  Director: Roumen Milev, M.D.

  8:00 a.m. – Noon

  Functional Neurological Disorder (Conversion Disorder): Update on Evaluation and Management

  Director: Gaston Baslet, M.D.

  8:00 a.m. – Noon

  Good Psychiatric Management for Borderline Personality Disorder

  Director: Brian Palmer, M.D.

  8:00 a.m. – Noon

  Talking With and Listening to Your Patients About Marijuana: What Psychiatrists Should Know

  Director: Henry Levine, M.D.

  8:00 a.m. – 3:00 p.m.

  Updates in Geriatric Psychiatry

  Director: Rajesh Tampi, M.D.

  8:00 a.m. – 3:00 p.m.

  Sunday, May 19, 2019

  First-Episode Psychosis for the General Clinician: From Assessment to Treatment

  Director: Dr. Steven Adelsheim, M.D.

  8:00 a.m. – Noon

  Imminent Suicide Risk Assessment in High-Risk Individuals Denying Suicidal Ideation or Intent

  Director: Igor Galynker, M.D.

  8:00 a.m. – Noon

  Mean Girls (And Boys): A Clinician’s Guide for Addressing School Violence

  Director: Anne McBride, M.D.

  8:00 a.m. – Noon

  Neuropsychiatric Masquerades: Medical and Neurological Disorders That Present With Psychiatric Symptoms

  Director: Jose Maldonado, M.D.

  8:00 a.m. – 5:00 p.m.

  Risk Assessment for Violence

  Director: Phillip Resnick, M.D.

  8:00 a.m. – Noon

  Eating Disorders for the General Psychiatrist

  Director: Evelyn Attia, M.D.

  1:00 p.m. – 5:00 p.m.

  Neuromodulation Essentials: ECT, TMS, DBS, VNS, and Other Innovative Techniques

  Director: Richard Holbert, M.D.

  1:00 p.m. – 5:00 p.m.

  Street Drugs and Disorders: Overview and Treatment of Dual Diagnosis Patients

  Director: John Tsuang, M.D.

  1:00 p.m. – 5:00 p.m.

  The Psychiatrist as Expert Witness: The Ins and Outs of Being a Forensic Consultant

  Director: Phillip Resnick, M.D.

  1:00 p.m. – 5:00 p.m.

  Monday, May 20, 2019

  Become a CPT Coding Master: Avoiding Hazards, Maximizing Opportunities, and Anticipating Changes

  Director: Gregory Harris, M.D.

  8:00 a.m. – Noon

  Emergency Psychiatry: The Basics and Beyond

  Director: Kimberly Nordstrom, M.D.

  8:00 a.m. – Noon

  Mind-Body Treatments for Global Mental Health Issues, Mass Disasters, Refugees, and PTSD: Lecture & Experiential

  Director: Patricia Gerbarg, M.D.

  8:00 a.m. – 5:00 p.m.

  Psychiatric Care for Transgender and Gender Non-Conforming (TGNC) Youth and Young Adults

  Director: Shervin Shadianloo, M.D.

  8:00 a.m. – Noon

  The Clinical Assessment of Malingered Mental Illness

  Director: Phillip Resnick, M.D.

  8:00 a.m. – Noon

  Clinically Relevant Forensic Psychiatry: A Practical Review

  Director: Tobias Wasser, M.D.

  1:00 p.m. – 5:00 p.m.

  Positive Psychiatry Across the Lifespan

  Director: Rama Gogineni, M.D.

  1:00 p.m. – 5:00 p.m.

  Psychiatric Disorders in Pregnancy and Postpartum: An Update

  Director: Shaila Misri, M.D.

  1:00 p.m. – 5:00 p.m.

  Treating Narcissistic Personality Disorder: Transference-Focused Psychotherapy

  Director: Frank Yeomans, M.D.

  1:00 p.m. – 5:00 p.m.

  Tuesday, May 21, 2019

  Evaluation and Treatment of Sexual Dysfunctions

  Director: Waguih Ishak, M.D.

  8:00 a.m. – Noon

  Integrating Neuroscience Into the Clinical Practice of Psychiatry: A Hands-on Practicum From the National Neuroscience Curriculum Initiative (NNCI)

  Director: Ashley Walker, M.D.

  8:00 a.m. – Noon

  Integrating Technology and Psychiatry

  Director: John Luo, M.D.

  8:00 a.m. – Noon

  Sleep Issues and Psychiatric Disorders: What Should Mental Health Professionals Know?

  Director: Karim Ghobrial-Sedky, M.D.

  8:00 a.m. – 5:00 p.m.

  Identifying and Helping Older Adults With Mild Neurocognitive Disorder

  Director: James Ellison, M.D.

  1:00 p.m. – 5:00 p.m.

  Motivational Interviewing: A Stepped-Care Approach to Advanced Skills

  Director: Steven Cole, M.D.

  1:00 p.m. – 5:00 p.m.

  These Are the Droids You're Looking For: An Expert Course on QTc, ECG, Psychotropic Medications, and Other Jedi Mind Tricks

  Director: Margo Funk, M.D.

  1:00 p.m. – 5:00 p.m.

  Wednesday, May 22, 2019

  Acute Brain Failure: Pathophysiology, Diagnosis, Management, and Sequelae of Delirium

  Director: Jose Maldonado, M.D.

  8:00 a.m. – Noon

  Autism Update for the Clinician: From Diagnosis to Behavioral and Pharmacological Interventions

  Director: Gagan Joshi, M.D.

  8:00 a.m. – 5:00 p.m.

  Disaster Psychiatry Review and Updates: Mass Violence, Climate Change and Ebola

  Director: Joshua Morganstein, M.D.

  8:00 a.m. – Noon

• Master Courses

  These in-depth courses are designed to broaden and enhance your professional skills and knowledge in special areas and include applicable publications from American Psychiatric Association Publishing.

  Saturday, May 18, 2019

  Office-Based Buprenorphine Treatment of Opioid Dependence

  Director: John Renner, M.D.

  8:00 a.m. – 5:00 p.m.

  Educational Objectives:

  1. Discuss the rationale and need for medication-assisted treatment (MAT) of opioid use disorder;
  2. Apply the pharmacological characteristics of opioids in clinical practice;
  3. Describe buprenorphine protocols for all phases of treatment and for optimal patient/treatment matching;
  4. Describe the legislative and regulatory requirements of office-based opioid pharmacotherapy; and
  5. Discuss treatment issues and management of opioid use disorder in adolescents, pregnant women, and patients with acute and/or chronic pain.

  Sunday, May 19, 2019

  Update on Pediatric Psychopharmacology

  Director: Karen Wagner, M.D., Ph.D.

  8:00 a.m. – 5:00 p.m.

  Educational Objectives:

  1. Demonstrate knowledge of current clinical guidelines for the use of pharmacotherapy in pediatric psychiatric disorders;
  2. Identify practical knowledge gained in the use of psychopharmacology and management of adverse effects; and
  3. Utilize recent research on pharmacotherapy in common psychiatric disorders of childhood.

  Monday, May 20, 2019

  Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice

  Director: Richard Bermudes, M.D.

  8:00 a.m. – 5:00 p.m.

  Educational Objectives:

  1. Explain the mechanism of action of TMS;
  2. Identify appropriate patients for TMS;
  3. Understand the efficacy of TMS for the treatment of major depression, OCD and other psychiatric disorders;
  4. Identify the risks and side effects of TMS; and
  5. Review the specifications of FDA-cleared TMS systems.

  Tuesday, May 21, 2019

  Essential Psychopharmacology

  Director: Alan Schatzberg, M.D.

  8:00 a.m. – 5:00 p.m.

  Educational Objectives:

  1. Provide an update on major classes of psychopharmacological agents;
  2. Review recent data on drugs under development—both positive and negative data;
  3. Provide a framework for integrating multiple modalities of treatment; and
  4. Review recent data on devices to treat major disorders.

  Wednesday, May 22, 2019

  Psychodynamic Therapy for Personality Pathology: Transference-Focused Psychotherapy—Extended

  Director: Eve Caligor, M.D.

  8:00 a.m. – 5:00 p.m.

  Educational Objectives:

  1. Apply recent developments in our understanding and classification of personality disorders to clinical practice;
  2. Perform clinically meaningful assessment of personality functioning and pathology;
  3. Understand the general clinical principles organizing psychodynamic therapy of personality disorders;
  4. Establish a treatment frame and contract with patients presenting with personality pathology at different levels of severity; and
  5. Understand the role of countertransference management in the treatment of patients with personality pathology at different levels of severity.